Afghanistan vs Vanuatu: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Afghanistan
42.0%
in 2025
Vanuatu
40.0%
in 2025
Afghanistan rank
182nd
Vanuatu rank
184th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Afghanistan
- Vanuatu
How they compare
Afghanistan currently reports 42.0% against 40.0% in Vanuatu, a difference of 2.0%.
That makes Afghanistan's figure about 1.1 times Vanuatu's.
The two have swapped places 3 times across 26 shared years of data; in 2000 it was Vanuatu ahead.
Afghanistan ranks 182nd and Vanuatu ranks 184th of 194 countries.
Afghanistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Afghanistan | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.0% | 0.0% | 8.0% | Afghanistan |
| 2010s | 37.8% | 0.0% | 37.8% | Afghanistan |
| 2020s | 40.8% | 19.0% | 21.8% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Afghanistan or Vanuatu?
- Afghanistan, at 42.0% against 40.0% in Vanuatu as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Afghanistan and Vanuatu?
- 2.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Vanuatu?
- 26 years are reported by both, from 2000 to 2025.
- How do Afghanistan and Vanuatu rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Afghanistan ranks 182nd and Vanuatu ranks 184th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.